Oukat H Tablet

The combination of these two agents provides complementary mechanisms of action, resulting in enhanced antihypertensive efficacy compared to monotherapy. Oukat H Tablet is indicated for the treatment of essential hypertension to achieve better blood pressure control and reduce the risk of cardiovascular morbidity and mortality. It is typically prescribed when monotherapy is insufficient or when combination therapy is deemed appropriate.

Patients should be monitored for electrolyte imbalances, renal function, and blood pressure response during treatment. Common adverse effects may include dizziness, hypotension, hyperkalemia, and electrolyte disturbances. Oukat H Tablet should be used under medical supervision with appropriate dosage adjustments based on clinical response and tolerability.